Liuyun Wu

机构：University of Electronic Science and Technology of China

发表论文 16 篇 · 总被引 529 次 · h-index 6

代表论文

• Immune-related adverse events of immune checkpoint inhibitors: a review (2023 · Frontiers in Immunology · 被引 427)
• A promising therapy for fatty liver disease: PCSK9 inhibitors (2024 · Phytomedicine · 被引 31)
• Ligusticum chuanxiong: a chemical, pharmacological and clinical review (2025 · Frontiers in Pharmacology · 被引 29)
• Unlocking the potential of fondaparinux: guideline for optimal usage and clinical suggestions (2023) (2024 · Frontiers in Pharmacology · 被引 12)
• Adverse drug events in Chinese elder inpatients: a retrospective review for evaluating the efficiency of the Global Trigger Tool (2023 · Frontiers in Medicine · 被引 9)
• Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (version 2) (2025 · Frontiers in Public Health · 被引 6)